标题
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
作者
关键词
Cardiovascular risk, Cholesterol, Fibrates, Hypertriglyceridemia, Insulin resistance, Metabolic syndrome, Obesity, Statins, Triglycerides, Type 2 diabetes
出版物
Cardiovascular Diabetology
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2014-12-03
DOI
10.1186/s12933-014-0159-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study
- (2014) Maria-Agata Miselli et al. Cardiovascular Diabetology
- Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A Mendelian Randomization Study
- (2014) M. Thomsen et al. CLINICAL CHEMISTRY
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- HDL and cardiovascular disease
- (2014) Daniel J Rader et al. LANCET
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Factors associated with postprandial lipemia and apolipoprotein A-V levels in individuals with familial combined hyperlipidemia
- (2014) Paloma Almeda-Valdes et al. BMC Endocrine Disorders
- The G-Protein-Coupled Long-Chain Fatty Acid Receptor GPR40 and Glucose Metabolism
- (2014) Tsutomu Tomita et al. Frontiers in Endocrinology
- Comparison of Statin Alone Versus Bezafibrate and Statin Combination in Patients With Diabetes Mellitus and Acute Coronary Syndrome
- (2013) Robert Klempfner et al. AMERICAN JOURNAL OF CARDIOLOGY
- High-density lipoprotein of patients with Type 2 Diabetes Mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate
- (2013) Xunliang Tong et al. Cardiovascular Diabetology
- Pitavastatin in cardiometabolic disease: therapeutic profile
- (2013) Luis Masana Cardiovascular Diabetology
- Statins in cardiometabolic disease: what makes pitavastatin different?
- (2013) Henry Ginsberg Cardiovascular Diabetology
- Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects
- (2013) Camila C Leança et al. Cardiovascular Diabetology
- Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the diabetes heart study
- (2013) Jeremy N Adams et al. Cardiovascular Diabetology
- Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes
- (2013) Ki-Bum Won et al. Cardiovascular Diabetology
- Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
- (2013) Eliot A Brinton et al. Cardiovascular Diabetology
- Statin diabetogenicity: guidance for clinicians
- (2013) Kausik Ray Cardiovascular Diabetology
- Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE study
- (2013) Tamio Teramoto et al. Cardiovascular Diabetology
- Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up
- (2013) Salvatore Novo et al. Cardiovascular Diabetology
- High-Density Lipoproteins
- (2013) Wijtske Annema et al. CIRCULATION JOURNAL
- Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies
- (2013) M. J. Chapman et al. CURRENT MEDICAL RESEARCH AND OPINION
- Common variants associated with plasma triglycerides and risk for coronary artery disease
- (2013) Ron Do et al. NATURE GENETICS
- n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia
- (2013) Tomoya Mita et al. Journal of Diabetes Investigation
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study
- (2012) Marit Herder et al. Cardiovascular Diabetology
- Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study
- (2012) Xuanqi An et al. Cardiovascular Diabetology
- Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
- (2012) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
- (2012) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study
- (2012) Tamio Teramoto et al. Cardiovascular Diabetology
- Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease
- (2012) Michel Farnier et al. Diabetes & Vascular Disease Research
- Mortality risk of triglyceride levels in patients with coronary artery disease
- (2012) Takatoshi Kasai et al. HEART
- Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events
- (2012) Evangelos C. Rizos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
- (2012) Lars Berglund et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Is it time to revise the HDL cholesterol hypothesis?
- (2012) Daniel J Rader et al. NATURE MEDICINE
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
- (2012) Alexander Tenenbaum et al. PLoS One
- Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life
- (2012) Danielle Swanson et al. Advances in Nutrition
- Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes
- (2011) Lutgarda Bozzetto et al. ATHEROSCLEROSIS
- Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease
- (2011) Laura Calabresi et al. ATHEROSCLEROSIS
- FoxO1 integrates insulin signaling to VLDL production
- (2011) Adama Kamagate et al. CELL CYCLE
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)–nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction
- (2011) R. Barazzoni et al. DIABETOLOGIA
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study
- (2010) H.A.W. Neil et al. ATHEROSCLEROSIS
- "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study
- (2010) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects
- (2010) Manoj Mathew et al. Cardiovascular Diabetology
- Effects of ethanol intake on lipoproteins and atherosclerosis
- (2010) Eliot A Brinton CURRENT OPINION IN LIPIDOLOGY
- Aldosterone, Sodium, and Hypertension
- (2010) John W. Funder HYPERTENSION
- Cardiovascular effects of marine omega-3 fatty acids
- (2010) Palaniappan Saravanan et al. LANCET
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Biological, clinical and population relevance of 95 loci for blood lipids
- (2010) Tanya M. Teslovich et al. NATURE
- Combination Lipid Therapy in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Particle size of apoB-48 carrying lipoproteins in remnant lipoproteins isolated from postprandial plasma
- (2010) T. Nakano et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults
- (2009) Earl S. Ford et al. ARCHIVES OF INTERNAL MEDICINE
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Triglycerides as vascular risk factors: new epidemiologic insights
- (2009) William B Kannel et al. CURRENT OPINION IN CARDIOLOGY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
- (2008) Samia Mora et al. CIRCULATION
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- (2008) Esther M. M. Ooi et al. CLINICAL SCIENCE
- Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL
- (2008) Anton FH Stalenhoef et al. CURRENT OPINION IN LIPIDOLOGY
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials
- (2008) A. Pandor et al. JOURNAL OF INTERNAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation